Revatis S.A. • Research & Development • Participation in research programs is a major asset
The participation of Revatis in several different multi-party collaborative research programs is progressively defining the company as a key player in the production of qualified cells.
Revatis establishes agreements with public and private research centers recognized in the sector, but also with downstream companies that need a supply of characterized stem cells.
Current research programs
Revatis' own research is carried out mainly in collaboration with the Center for Oxygen, Research and Development (CORD) of the University of Liège. They focus on differentiation capacities, mitochondrial dysfunction and modulation of neutrophil activity.
Biobank
Revatis has an accredited biobank to store mdMSCs from healthy volunteers for various ongoing or future R&D programs.
Purchase of stem cells
Muscle derived Mesenchymal Stem Cells from healthy volunteers are available for any therapeutic or non-therapeutic R&D program.